Cite
Intraventricular colistin sulphate as a last resort therapy in a patient with multidrug‐resistant Acinetobacter baumannii induced post‐neurosurgical ventriculitis.
MLA
Yu, Xu‐Ben, et al. “Intraventricular Colistin Sulphate as a Last Resort Therapy in a Patient with Multidrug‐resistant Acinetobacter Baumannii Induced Post‐neurosurgical Ventriculitis.” British Journal of Clinical Pharmacology, vol. 88, no. 7, July 2022, pp. 3490–94. EBSCOhost, https://doi.org/10.1111/bcp.15238.
APA
Yu, X., Huang, Y., Zhang, X., Wang, Y., Shi, D., Zhang, C., Chen, J., Wang, X., & Lin, G. (2022). Intraventricular colistin sulphate as a last resort therapy in a patient with multidrug‐resistant Acinetobacter baumannii induced post‐neurosurgical ventriculitis. British Journal of Clinical Pharmacology, 88(7), 3490–3494. https://doi.org/10.1111/bcp.15238
Chicago
Yu, Xu‐Ben, Yue‐Yue Huang, Xiao‐Shan Zhang, Yu‐Zhen Wang, Da‐Wei Shi, Chun‐Hong Zhang, Jie Chen, Xiao‐Rong Wang, and Guan‐Yang Lin. 2022. “Intraventricular Colistin Sulphate as a Last Resort Therapy in a Patient with Multidrug‐resistant Acinetobacter Baumannii Induced Post‐neurosurgical Ventriculitis.” British Journal of Clinical Pharmacology 88 (7): 3490–94. doi:10.1111/bcp.15238.